Medlive Technology Past Earnings Performance
Past criteria checks 4/6
Medlive Technology has been growing earnings at an average annual rate of 47.3%, while the Healthcare Services industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 20.9% per year. Medlive Technology's return on equity is 6.4%, and it has net margins of 60.2%.
Key information
47.3%
Earnings growth rate
39.8%
EPS growth rate
| Healthcare Services Industry Growth | 22.3% |
| Revenue growth rate | 20.9% |
| Return on equity | 6.4% |
| Net Margin | 60.2% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medlive Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 482 | 290 | 196 | 0 |
| 31 Mar 24 | 447 | 266 | 187 | 0 |
| 31 Dec 23 | 412 | 242 | 177 | 0 |
| 30 Sep 23 | 384 | 216 | 167 | 0 |
| 30 Jun 23 | 356 | 189 | 158 | 0 |
| 31 Mar 23 | 335 | 153 | 155 | 0 |
| 31 Dec 22 | 314 | 117 | 151 | 0 |
| 30 Sep 22 | 300 | 83 | 143 | 0 |
| 30 Jun 22 | 286 | 48 | 135 | 0 |
| 31 Mar 22 | 285 | 44 | 131 | 0 |
| 31 Dec 21 | 284 | 41 | 128 | 0 |
| 30 Sep 21 | 270 | 55 | 109 | 0 |
| 30 Jun 21 | 255 | 70 | 89 | 0 |
| 31 Mar 21 | 234 | 78 | 71 | 0 |
| 31 Dec 20 | 214 | 85 | 53 | 0 |
| 31 Dec 19 | 122 | 31 | 37 | 0 |
| 31 Dec 18 | 83 | 14 | 31 | 0 |
Quality Earnings: 2192 has a high level of non-cash earnings.
Growing Profit Margin: 2192's current net profit margins (60.2%) are higher than last year (53.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2192's earnings have grown significantly by 47.3% per year over the past 5 years.
Accelerating Growth: 2192's earnings growth over the past year (53.5%) exceeds its 5-year average (47.3% per year).
Earnings vs Industry: 2192 earnings growth over the past year (53.5%) exceeded the Healthcare Services industry 11.9%.
Return on Equity
High ROE: 2192's Return on Equity (6.4%) is considered low.